Print Page

Medicine recalls

 
Canada: Recall: Kogenate FS 2000 units/vial (with Vial Adapter)
 
Health Canada announced that Bayer Inc. is recalling Kogenate FS 2000units/vial (with Vial Adapter) containing lyophilized Powder for Injection or Continuous Infusion as out of specification result for potency of the active ingredient during shelf-life testing was noted. The affected lot numbers are 270RH0P and 270TN19. The depth of distribution of the product is hospitals and healthcare facilities (clinics) across Canada except Quebec.

Health Canada classified the hazard level of the recall as Type III, i.e. a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.

Please refer to the following website in Health Canada for details: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../59580r-eng.php

In Hong Kong, the above product is not a registered pharmaceutical product.


Ends/ Thursday, July 28, 2016
Issued at HKT 15:00
 
Related Information:
China: Bayer voluntarily recalls specific batches of Recombinant Human Coagulati... Posted 2016-08-26
The United States: Voluntary Drug Recall Extension - Kogenate FS Antihemophilic ... Posted 2016-08-23
Taiwan: Recall of "科基"血凝素第八因子注射劑(重組體)1000IU/瓶 [KOGENATE FS, ANTIHEMOPHILIC FACTO... Posted 2016-08-19
The United Kingdom: Company-led recall: Kogenate Bayer Powder and Solvent for So... Posted 2016-08-12
 
back